Form 4: Marimed Inc. Director Eva Selhub Reports Transaction in Company Stock
SEC Form 4 Filing
Director Eva Selhub reports acquisition and disposal of Marimed Inc. stock related to RSU conversion.
Summary
- On May 21, 2025, Eva Selhub, a director of Marimed Inc., reported a transaction involving the company's common stock.
- The transaction involved the conversion of 132,353 Restricted Stock Units (RSUs) into common stock.
- These RSUs vested in full on May 21, 2025, and were granted on May 15, 2025, as compensation for board service.
- Following the transaction, Ms. Selhub directly owns 240,686 shares of Marimed Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Positives
- The transaction reflects the vesting of previously granted compensation, aligning director interests with shareholder value.
Industry Context
This filing is a routine disclosure related to insider transactions, common for publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider stock ownership.
Key Dates
| Date | Description |
|---|---|
| 05/15/2025 | RSUs were granted to Eva Selhub. |
| 05/21/2025 | RSUs vested in full and were converted to common stock; transaction date. |
Keywords
Form 4, Marimed Inc., MRMD, Eva Selhub, Director, Restricted Stock Units, RSU, Beneficial Ownership, Stock Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.